System and methods for deriving gene signature biomarkers of response to PD-1 antagonists
- Resource Type
- Patent
- Authors
- Source
- Subject
- Language
A gene expression platform, which is a combination of a set of genes that are correlated with response to a PD-1 antagonist in multiple tumor types and a normalization gene set, is disclosed. A method and system of using the gene expression platform to derive gene signature biomarkers of anti-tumor response to a PD-1 antagonist and to test patient samples for predictive gene signature biomarkers are also disclosed.